Australia's Neurotech falls on drug request denial by U.S. FDA

Neurotech International

04/10/2024 02:29

** Shares of Neurotech International  NTI.AX  fall as much
as 17.2% to A$0.048, set to lose most since May 26, 2023 - if
current trends hold
    ** The biopharmaceutical development firm says the US Food
and Drug Administration (FDA) denied request for use of co's
medicine in children and adults
    ** Stock hits its lowest level since Aug. 30, 2023
    ** 1.9 mln shares change hands, compared with the 30-day
average volume of 846,268
    ** Stock has lost over 13% so far this week
    ** Stock is down 26% YTD as of 0121 GMT

 (Reporting by Rajasik Mukherjee in Bengaluru)
 ((Rajasik.Mukherjee@thomsonreuters.com;))